MSSP ACO – Baptist Accountable Care

Baptist Accountable Care, LLC
1445 Ross Avenue, Suite 1400
Dallas, TX 75020

ACO Primary Contact
Primary Contact Name Robin Clark
Primary Contact Phone Number 210-297-1332
Primary Contact Email Address

Organizational Information

 ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Physician Primecare, Inc  N
San Antonio Premier Internal Medicine, PLLC  N
South Alamo Medical Group  N
VHS San Antonio Partners, LLC  Y

 Key ACO clinical and administrative leadership:

Robin Clark ACO Executive
Ayham Shneker Medical Director
Melanie Roberts Compliance Officer
Sahana Sharan Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Types of ACO participants, or combinations of participants, that formed the ACO:
Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Shared Savings Distribution

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information N/A 80.51
ACO-2 CAHPS: How Well Your Providers Communicate N/A 93.01
ACO-3 CAHPS: Patients' Rating of Provider N/A 92.25
ACO-4 CAHPS: Access to Specialists N/A 83.49
ACO-5 CAHPS: Health Promotion and Education N/A 60.32
ACO-6 CAHPS: Shared Decision Making N/A 75.40
ACO-7 CAHPS: Health Status/Functional Status N/A 72.30
ACO-34 CAHPS: Stewardship of Patient Resources N/A 26.97
ACO-8 Risk-Standardized, All Condition Readmission N/A 14.70
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) N/A 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes N/A 53.20
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure N/A 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions N/A 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) N/A 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) N/A 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements N/A 82.72
ACO-39 Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13 Falls: Screening for Future Fall Risk N/A 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization N/A 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults N/A 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up N/A 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention N/A 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan N/A 53.63
ACO-19 Colorectal Cancer Screening N/A 61.52
ACO-20 Breast Cancer Screening N/A 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented N/A 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease N/A 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control N/A 18.24
ACO-41 Diabetes: Eye Exam N/A 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure N/A 70.69
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic N/A 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.   

Payment Rule Waivers

No, our ACO does not use the SNF 3-Day Rule Waiver.